#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

Epstein-Barr Virus Infection of Polarized Epithelial Cells via the Basolateral Surface by Memory B Cell-Mediated Transfer Infection


Epstein Barr virus (EBV) exhibits a distinct tropism for both B cells and epithelial cells. The virus persists as a latent infection of memory B cells in healthy individuals, but a role for infection of normal epithelial is also likely. Infection of B cells is initiated by the interaction of the major EBV glycoprotein gp350 with CD21 on the B cell surface. Fusion is triggered by the interaction of the EBV glycoprotein, gp42 with HLA class II, and is thereafter mediated by the core fusion complex, gH/gL/gp42. In contrast, direct infection of CD21-negative epithelial cells is inefficient, but efficient infection can be achieved by a process called transfer infection. In this study, we characterise the molecular interactions involved in the three stages of transfer infection of epithelial cells: (i) CD21-mediated co-capping of EBV and integrins on B cells, and activation of the adhesion molecules, (ii) conjugate formation between EBV-loaded B cells and epithelial cells via the capped adhesion molecules, and (iii) interaction of EBV glycoproteins with epithelial cells, with subsequent fusion and uptake of virions. Infection of epithelial cells required the EBV gH and gL glycoproteins, but not gp42. Using an in vitro model of normal polarized epithelia, we demonstrated that polarization of the EBV receptor(s) and adhesion molecules restricted transfer infection to the basolateral surface. Furthermore, the adhesions between EBV-loaded B cells and the basolateral surface of epithelial cells included CD11b on the B cell interacting with heparan sulphate moieties of CD44v3 and LEEP-CAM on epithelial cells. Consequently, transfer infection was efficiently mediated via CD11b-positive memory B cells but not by CD11b–negative naïve B cells. Together, these findings have important implications for understanding the mechanisms of EBV infection of normal and pre-malignant epithelial cells in vivo.


Vyšlo v časopise: Epstein-Barr Virus Infection of Polarized Epithelial Cells via the Basolateral Surface by Memory B Cell-Mediated Transfer Infection. PLoS Pathog 7(5): e32767. doi:10.1371/journal.ppat.1001338
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.ppat.1001338

Souhrn

Epstein Barr virus (EBV) exhibits a distinct tropism for both B cells and epithelial cells. The virus persists as a latent infection of memory B cells in healthy individuals, but a role for infection of normal epithelial is also likely. Infection of B cells is initiated by the interaction of the major EBV glycoprotein gp350 with CD21 on the B cell surface. Fusion is triggered by the interaction of the EBV glycoprotein, gp42 with HLA class II, and is thereafter mediated by the core fusion complex, gH/gL/gp42. In contrast, direct infection of CD21-negative epithelial cells is inefficient, but efficient infection can be achieved by a process called transfer infection. In this study, we characterise the molecular interactions involved in the three stages of transfer infection of epithelial cells: (i) CD21-mediated co-capping of EBV and integrins on B cells, and activation of the adhesion molecules, (ii) conjugate formation between EBV-loaded B cells and epithelial cells via the capped adhesion molecules, and (iii) interaction of EBV glycoproteins with epithelial cells, with subsequent fusion and uptake of virions. Infection of epithelial cells required the EBV gH and gL glycoproteins, but not gp42. Using an in vitro model of normal polarized epithelia, we demonstrated that polarization of the EBV receptor(s) and adhesion molecules restricted transfer infection to the basolateral surface. Furthermore, the adhesions between EBV-loaded B cells and the basolateral surface of epithelial cells included CD11b on the B cell interacting with heparan sulphate moieties of CD44v3 and LEEP-CAM on epithelial cells. Consequently, transfer infection was efficiently mediated via CD11b-positive memory B cells but not by CD11b–negative naïve B cells. Together, these findings have important implications for understanding the mechanisms of EBV infection of normal and pre-malignant epithelial cells in vivo.


Zdroje

1. RickinsonA

KieffE

2006 Fields Virology; DM K, PM H, eds. Philadelphia Lippincott Williams & Wilkins 2655 2700

2. NemerowGR

WolfertR

McNaughtonME

CooperNR

1985 Identification and characterization of the Epstein-Barr virus receptor on human B lymphocytes and its relationship to the C3d complement receptor (CR2). J Virol 55 347 351

3. FingerothJD

WeisJJ

TedderTF

StromingerJL

BiroPA

1984 Epstein-Barr virus receptor of human B lymphocytes is the C3d receptor CR2. Proc Natl Acad Sci U S A 81 4510 4514

4. LiQ

SpriggsMK

KovatsS

TurkSM

ComeauMR

1997 Epstein-Barr virus uses HLA class II as a cofactor for infection of B lymphocytes. J Virol 71 4657 4662

5. MolesworthSJ

LakeCM

BorzaCM

TurkSM

Hutt-FletcherLM

2000 Epstein-Barr virus gH is essential for penetration of B cells but also plays a role in attachment of virus to epithelial cells. J Virol 74 6324 6332

6. OdaT

ImaiS

ChibaS

TakadaK

2000 Epstein-Barr virus lacking glycoprotein gp85 cannot infect B cells and epithelial cells. Virology 276 52 58

7. JiangR

GuX

NathanCO

Hutt-FletcherL

2008 Laser-capture microdissection of oropharyngeal epithelium indicates restriction of Epstein-Barr virus receptor/CD21 mRNA to tonsil epithelial cells. J Oral Pathol Med 37 626 633

8. FeederleR

NeuhierlB

BannertH

GeletnekyK

Shannon-LoweC

2007 Epstein-Barr virus B95.8 produced in 293 cells shows marked tropism for differentiated primary epithelial cells and reveals interindividual variation in susceptibility to viral infection. Int J Cancer 121 588 594

9. TugizovSM

BerlineJW

PalefskyJM

2003 Epstein-Barr virus infection of polarized tongue and nasopharyngeal epithelial cells. Nat Med 9 307 314

10. ImaiS

NishikawaJ

TakadaK

1998 Cell-to-cell contact as an efficient mode of Epstein-Barr virus infection of diverse human epithelial cells. J Virol 72 4371 4378

11. Shannon-LoweCD

NeuhierlB

BaldwinG

RickinsonAB

DelecluseHJ

2006 Resting B cells as a transfer vehicle for Epstein-Barr virus infection of epithelial cells. Proc Natl Acad Sci U S A 103 7065 7070

12. TohyaK

UmemotoE

MiyasakaM

2010 Microanatomy of lymphocyte-endothelial interactions at the high endothelial venules of lymph nodes. Histol Histopathol 25 781 794

13. LiuY

ShawSK

MaS

YangL

LuscinskasFW

2004 Regulation of leukocyte transmigration: cell surface interactions and signaling events. J Immunol 172 7 13

14. HudnallSD

GeY

WeiL

YangNP

WangHQ

2005 Distribution and phenotype of Epstein-Barr virus-infected cells in human pharyngeal tonsils. Mod Pathol 18 519 527

15. Shannon-LoweC

BaldwinG

FeederleR

BellA

RickinsonA

2005 Epstein-Barr virus-induced B-cell transformation: quantitating events from virus binding to cell outgrowth. J Gen Virol 86 3009 3019

16. Shannon-LoweC

AdlandE

BellAI

DelecluseHJ

RickinsonAB

2009 Features distinguishing Epstein-Barr virus infections of epithelial cells and B cells: viral genome expression, genome maintenance, and genome amplification. J Virol 83 7749 7760

17. DelecluseHJ

HilsendegenT

PichD

ZeidlerR

HammerschmidtW

1998 Propagation and recovery of intact, infectious Epstein-Barr virus from prokaryotic to human cells. Proc Natl Acad Sci U S A 95 8245 8250

18. JanzA

OezelM

KurzederC

MautnerJ

PichD

2000 Infectious Epstein-Barr virus lacking major glycoprotein BLLF1 (gp350/220) demonstrates the existence of additional viral ligands. J Virol 74 10142 10152

19. NeuhierlB

FeederleR

HammerschmidtW

DelecluseHJ

2002 Glycoprotein gp110 of Epstein-Barr virus determines viral tropism and efficiency of infection. Proc Natl Acad Sci U S A 99 15036 15041

20. DenekaM

Pelchen-MatthewsA

BylandR

Ruiz-MateosE

MarshM

2007 In macrophages, HIV-1 assembles into an intracellular plasma membrane domain containing the tetraspanins CD81, CD9, and CD53. J Cell Biol 177 329 341

21. Lottin-DivouxS

JeanD

Le RomancerM

FradeR

2006 Activation of Epstein-Barr virus/C3d receptor (gp140, CR2, CD21) on human B lymphoma cell surface triggers Cbl tyrosine phosphorylation, its association with p85 subunit, Crk-L and Syk and its dissociation with Vav. Cell Signal 18 1219 1225

22. BarraultDV

KnightAM

2004 Distinct sequences in the cytoplasmic domain of complement receptor 2 are involved in antigen internalization and presentation. J Immunol 172 3509 3517

23. IanelliCJ

DeLellisR

Thorley-LawsonDA

1998 CD48 binds to heparan sulfate on the surface of epithelial cells. J Biol Chem 273 23367 23375

24. MeeCJ

GroveJ

HarrisHJ

HuK

BalfeP

2008 Effect of cell polarization on hepatitis C virus entry. J Virol 82 461 470

25. ZenK

LiuDQ

LiLM

ChenCX

GuoYL

2009 The heparan sulfate proteoglycan form of epithelial CD44v3 serves as a CD11b/CD18 counter-receptor during polymorphonuclear leukocyte transepithelial migration. J Biol Chem 284 3768 3776

26. CalderwoodMA

VenkatesanK

XingL

ChaseMR

VazquezA

2007 Epstein-Barr virus and virus human protein interaction maps. Proc Natl Acad Sci U S A 104 7606 7611

27. BarelM

Le RomancerM

FradeR

2001 Activation of the EBV/C3d receptor (CR2, CD21) on human B lymphocyte surface triggers tyrosine phosphorylation of the 95-kDa nucleolin and its interaction with phosphatidylinositol 3 kinase. J Immunol 166 3167 3173

28. TessierJ

CuvillierA

GlaudetF

KhamlichiAA

2007 Internalization and molecular interactions of human CD21 receptor. Mol Immunol 44 2415 2425

29. PerryM

WhyteA

1998 Immunology of the tonsils. Immunol Today 19 414 421

30. PerryME

1994 The specialised structure of crypt epithelium in the human palatine tonsil and its functional significance. J Anat 185 Pt 1 111 127

31. DebertinAS

TschernigT

TonjesH

KleemannWJ

TrogerHD

2003 Nasal-associated lymphoid tissue (NALT): frequency and localization in young children. Clin Exp Immunol 134 503 507

32. LevyS

ToddSC

MaeckerHT

1998 CD81 (TAPA-1): a molecule involved in signal transduction and cell adhesion in the immune system. Annu Rev Immunol 16 89 109

33. AkiyamaSK

1996 Integrins in cell adhesion and signaling. Hum Cell 9 181 186

34. NguyenDH

GiriB

CollinsG

TaubDD

2005 Dynamic reorganization of chemokine receptors, cholesterol, lipid rafts, and adhesion molecules to sites of CD4 engagement. Exp Cell Res 304 559 569

35. KhunkaewlaP

SchillerHB

PasterW

LeksaV

CermakL

2008 LFA-1-mediated leukocyte adhesion regulated by interaction of CD43 with LFA-1 and CD147. Mol Immunol 45 1703 1711

36. JungeS

BrennerB

Lepple-WienhuesA

NiliusB

LangF

1999 Intracellular mechanisms of L-selectin induced capping. Cell Signal 11 301 308

37. ChigaevA

WallerA

AmitO

HalipL

BologaCG

2009 Real-time analysis of conformation-sensitive antibody binding provides new insights into integrin conformational regulation. J Biol Chem 284 14337 14346

38. Puklin-FaucherE

VogelV

2009 Integrin activation dynamics between the RGD-binding site and the headpiece hinge. J Biol Chem 284 36557 36568

39. DransfieldI

CabanasC

CraigA

HoggN

1992 Divalent cation regulation of the function of the leukocyte integrin LFA-1. J Cell Biol 116 219 226

40. ChesnokovaLS

NishimuraSL

Hutt-FletcherLM

2009 Fusion of epithelial cells by Epstein-Barr virus proteins is triggered by binding of viral glycoproteins gHgL to integrins alphavbeta6 or alphavbeta8. Proc Natl Acad Sci U S A 106 20464 20469

41. XuW

HeB

ChiuA

ChadburnA

ShanM

2007 Epithelial cells trigger frontline immunoglobulin class switching through a pathway regulated by the inhibitor SLPI. Nat Immunol 8 294 303

42. FagarasanS

KinoshitaK

MuramatsuM

IkutaK

HonjoT

2001 In situ class switching and differentiation to IgA-producing cells in the gut lamina propria. Nature 413 639 643

43. Rodriguez-BoulanE

PowellSK

1992 Polarity of epithelial and neuronal cells. Annu Rev Cell Biol 8 395 427

44. ShinK

FoggVC

MargolisB

2006 Tight junctions and cell polarity. Annu Rev Cell Dev Biol 22 207 235

45. HadinotoV

ShapiroM

SunCC

Thorley-LawsonDA

2009 The dynamics of EBV shedding implicate a central role for epithelial cells in amplifying viral output. PLoS Pathog 5 e1000496

Štítky
Hygiena a epidemiológia Infekčné lekárstvo Laboratórium

Článok vyšiel v časopise

PLOS Pathogens


2011 Číslo 5
Najčítanejšie tento týždeň
Najčítanejšie v tomto čísle
Kurzy

Zvýšte si kvalifikáciu online z pohodlia domova

Aktuální možnosti diagnostiky a léčby litiáz
nový kurz
Autori: MUDr. Tomáš Ürge, PhD.

Všetky kurzy
Prihlásenie
Zabudnuté heslo

Zadajte e-mailovú adresu, s ktorou ste vytvárali účet. Budú Vám na ňu zasielané informácie k nastaveniu nového hesla.

Prihlásenie

Nemáte účet?  Registrujte sa

#ADS_BOTTOM_SCRIPTS#